Julie Hamra

Head of Global Health Partnership, Pfizer

Julie Hamra is the Head of Global Health Partnership at Pfizer, where she works with partners to advance policies, strategies, and innovative collaborations that ensure sustainable access to vaccines and medicine for everyone, everywhere. She has extensive experience working with global health organisations and country governments. Ms Hamra deeply believes that advancing partnerships behind a shared mission can transform health system barriers to address the health equity gap in lower-income, under-served populations. In her almost 15 years at Pfizer, Ms Hamra has worked across all geographies and disease areas, with the last decade largely focused on vaccines.

Before joining the pharmaceutical industry, she worked at the University of North Carolina-Chapel Hill School of Medicine as part of an interdisciplinary research team developing novel research techniques and therapies in fields including autoimmune disease and gene therapy. She has held various leadership and management roles in organisations seeking to ensure equitable health outcomes through access to care and inclusion in research and clinical trials.

Her passion to address unmet medical needs eventually led her to a career in public health and policy. Currently Ms Hamra represents IFPMA at the Gavi Programme & Policy Committee. She is a member of the Imperial Chanjo Hub Board, and African-led academic-industry hub that is researching, developing and implementing a bottom-up approach to establishing local vaccine manufacturing for endemic diseases of importance to Africa. She is also a member of the Pandemic Fund’s External Advisory Council.